79
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD

, , , , , & show all
Pages 357-365 | Published online: 13 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kjell E J Håkansson, Charlotte S Ulrik, Nina S Godtfredsen, Thomas Kallemose, Ove Andersen, Jesper Eugen-Olsen, Kristoffer Marsaa & Line J H Rasmussen. (2020) High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 733-743.
Read now
S. Desmedt, V. Desmedt, J. R. Delanghe, R. Speeckaert & M. M. Speeckaert. (2017) The intriguing role of soluble urokinase receptor in inflammatory diseases. Critical Reviews in Clinical Laboratory Sciences 54:2, pages 117-133.
Read now

Articles from other publishers (8)

Kai Gong, Jiao Xu & Jianlei Tang. (2022) Diagnostic and Prognostic Value of Deregulated Circulating Long Non-coding RNA TUG1 in Elderly Patients with Severe Pneumonia. Inflammation 46:1, pages 313-321.
Crossref
Elizabeth Dhummakupt, Conor Jenkins, Gabrielle Rizzo, Allison Melka, Daniel Carmany, Amber Prugh, Jennifer Horsmon, Julie Renner & Daniel Angelini. (2022) Proteomic, Metabolomic, and Lipidomic Analyses of Lung Tissue Exposed to Mustard Gas. Metabolites 12:9, pages 815.
Crossref
Line Jee Hartmann Rasmussen, Jens Emil Vang Petersen & Jesper Eugen-Olsen. (2021) Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation. Frontiers in Immunology 12.
Crossref
Jafar Sarif, Deblina Raychaudhuri, Ranit D’Rozario, Purbita Bandopadhyay, Praveen Singh, Priyanka Mehta, Md. Asmaul Hoque, Bishnu Prasad Sinha, Manoj Kushwaha, Shweta Sahni, Priti Devi, Partha Chattopadhyay, Shekhar Ranjan Paul, Yogiraj Ray, Kausik Chaudhuri, Sayantan Banerjee, Debajyoti Majumdar, Bibhuti Saha, Biswanath Sharma Sarkar, Prasun Bhattacharya, Shilpak Chatterjee, Sandip Paul, Pramit Ghosh, Rajesh Pandey, Shantanu Sengupta & Dipyaman Ganguly. (2021) Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19. Frontiers in Immunology 12.
Crossref
Zekiye Kula Sever, Haci Ahmet Bircan, Fevziye Burcu Sirin, Sehnaz Evrimler, Seda Celik & Neslihan Merd. (2020) Serum biomarkers in patients with stable and exacerbated COPD‐bronchiectasis overlap syndrome. The Clinical Respiratory Journal 14:11, pages 1032-1039.
Crossref
Martin Schultz, Line J. H. Rasmussen, Thomas Høi-Hansen, Erik Kjøller, Birgitte N. Jensen, Morten N. Lind, Lisbet Ravn, Thomas Kallemose, Theis Lange, Lars Køber, Lars S. Rasmussen, Jesper Eugen-Olsen & Kasper K. Iversen. (2019) Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy. Disease Markers 2019, pages 1-8.
Crossref
Renáta M. Böcskei, Béla Benczúr, György Losonczy, Miklós Illyés, Attila Cziráki, Veronika Müller, Anikó Bohács & András Bikov. (2019) Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD. Lung 197:2, pages 189-197.
Crossref
Jyotshna Mandal, Michael Roth, Luigi Costa, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm & Daiana Stolz. (2015) Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease. Respiration 90:5, pages 357-368.
Crossref